Camillo Ricordi M.D. is Professor and Director of the Diabetes Research Institute and the Cell Transplant Program at the University of Miami where he leads a team of over 150 committed scientists and researchers with the single objective and mission to find a cure for type 1 diabetes.
Ricordi's major contributions include developing the method for large scale production of human pancreatic islets (the insulin producing cells), the performance of the first series of successful islet transplants to reverse diabetes accompanied by work to develop novel strategies around transplantation that avoid the need for anti-rejection medications. He's currently serving as Chairperson of the Steering Committee of the NIH Clinical Islet Transplantation Consortium, which completed the first FDA approved Phase III trial of islet transplantation.
Ricordi's research efforts are now focused on the reversal of autoimmunity in type 1 diabetes and on the transplantation (and regeneration) of insulin producing cells. As Founding President of The Cure Alliance, Ricordi promotes international collaboration on cure-focused research. He has authored over 700 scientific publications and as been awarded 22 patents.
